 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 10/12/2026 |
$31.84 |
$32.22 |
$30.69 |
$30.82 |
647.80K | | 10/13/2026 |
$30.60 |
$30.99 |
$30.10 |
$30.21 |
1.17M | | 10/14/2026 |
$30.07 |
$31.11 |
$29.67 |
$30.97 |
930.90K | | 10/15/2026 |
$31.70 |
$32.84 |
$31.35 |
$32.32 |
2.05M | | 10/16/2026 |
$32.35 |
$32.52 |
$31.16 |
$31.32 |
952.70K |
 |
| Agios Pharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. | |
 |

Agios Pharmaceuticals (AGIO) has the following price history information. Looking back at AGIO historical stock prices for the last five trading days, on October 12, 2026, AGIO opened at $31.84, traded as high as $32.22 and as low as $30.69, and closed at $30.82. Trading volume was a total of 647.80K shares. On October 13, 2026, AGIO opened at $30.60, traded as high as $30.99 and as low as $30.10, and closed at $30.21. Trading volume was a total of 1.17M shares. On October 14, 2026, AGIO opened at $30.07, traded as high as $31.11 and as low as $29.67, and closed at $30.97. Trading volume was a total of 930.90K shares. On October 15, 2026, AGIO opened at $31.70, traded as high as $32.84 and as low as $31.35, and closed at $32.32. Trading volume was a total of 2.05M shares. On October 16, 2026, AGIO opened at $32.35, traded as high as $32.52 and as low as $31.16, and closed at $31.32. Trading volume was a total of 952.70K shares.
AGIO Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Agios Pharmaceuticals shares, starting with a $10,000 purchase of AGIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/18/2016 |
|
| End date: |
10/16/2026 |
|
| Start price/share: |
$49.26 |
|
| End price/share: |
$31.32 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-36.42% |
|
| Average Annual Total Return: |
-4.43% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$6,356.47 |
|
| Years: |
10.00 |
|
|
 |
| Date |
Close |
| 10/12/2026 | $30.82 | | 10/13/2026 | $30.21 | | 10/14/2026 | $30.97 | | 10/15/2026 | $32.32 | | 10/16/2026 | $31.32 |
|
 |